Conclusion
The risk from COVID-19 in pregnancy is low. Our review has demonstrated
a non-significant rise in the frequency of IUD in the first six months
2020 compared to those in 2019, in addition to a significantly lower
lymphocyte count- a marker known to be associated with COVID-19. This
acts as proof of concept and warrants ongoing investigation to explore
the link between COVID-19 and disorders of poor placental perfusion,
particularly the rates of IUD.